Trending Science
For AI agents
Use Trending Science through the MCP server
Top signals
Rare-disease research spans gene therapy, AI diagnosis, and new molecular targets
Coverage points to gene therapy, AI-assisted diagnosis, and molecular studies as active rare-disease areas, while experts debate evidence standards and patients still face diagnostic uncertainty.
Alfalfa sprouts linked to a multistate E. coli and Salmonella outbreak
U.S. health officials are investigating E. coli and Salmonella infections in 15 states, with alfalfa sprouts identified as the suspected food link.
OpenAI claims an AI-generated solution to the Navier–Stokes problem
OpenAI says an AI system found a finite-time singularity in the Navier–Stokes equations and released a paper plus Lean formalization, but outside mathematicians are challenging the claim.
Trump picks Heidi Overton to lead the FDA
President Donald Trump has picked Dr. Heidi Overton, a White House Domestic Policy Council deputy, to lead the FDA, though the coverage does not establish Senate confirmation.
Lindsay Clancy trial turns on postpartum psychosis and criminal responsibility
The defense has rested in Lindsay Clancy’s triple-murder trial, arguing postpartum psychosis made her legally not responsible for killing her three children.
Drug pricing policy is shifting across U.S. markets and payment models
Drug pricing debates are expanding from U.S. negotiations and most-favored-nation deals to subscription models, while affordability, access, and effects on innovation remain unsettled.
Flight attendants and pilots show the highest reported radiation-related cancer mortality
A study of more than 500 occupations found flight attendants and pilots had the highest reported shares of radiation-related cancer deaths, but causation remains unproven.
Judge rules former Abercrombie CEO competent to face sex-trafficking trial
A federal judge ruled former Abercrombie & Fitch CEO Michael Jeffries mentally competent to stand trial on alleged sex-trafficking charges after months of hospitalization.
Diagnostics are moving from central labs toward point-of-care and consumer testing
Coverage spans faster point-of-care molecular tests, cancer treatment-matching assays, and consumer blood-based reports, alongside laboratory services for infectious disease, genomics, and aging.
FDA approval puts an oral JAK-pathway treatment for dermatomyositis in focus
Coverage centers on reported FDA approval of Lisraya, an oral JAK-pathway drug for adults with dermatomyositis, alongside broader research and industry activity in inflammation.
Signals Gallery
Rare-disease research spans gene therapy, AI diagnosis, and new molecular targets
Coverage points to gene therapy, AI-assisted diagnosis, and molecular studies as active rare-disease areas, while experts debate evidence standards and patients still face diagnostic uncertainty.
Alfalfa sprouts linked to a multistate E. coli and Salmonella outbreak
U.S. health officials are investigating E. coli and Salmonella infections in 15 states, with alfalfa sprouts identified as the suspected food link.
OpenAI claims an AI-generated solution to the Navier–Stokes problem
OpenAI says an AI system found a finite-time singularity in the Navier–Stokes equations and released a paper plus Lean formalization, but outside mathematicians are challenging the claim.
Trump picks Heidi Overton to lead the FDA
President Donald Trump has picked Dr. Heidi Overton, a White House Domestic Policy Council deputy, to lead the FDA, though the coverage does not establish Senate confirmation.
Lindsay Clancy trial turns on postpartum psychosis and criminal responsibility
The defense has rested in Lindsay Clancy’s triple-murder trial, arguing postpartum psychosis made her legally not responsible for killing her three children.
Drug pricing policy is shifting across U.S. markets and payment models
Drug pricing debates are expanding from U.S. negotiations and most-favored-nation deals to subscription models, while affordability, access, and effects on innovation remain unsettled.
Flight attendants and pilots show the highest reported radiation-related cancer mortality
A study of more than 500 occupations found flight attendants and pilots had the highest reported shares of radiation-related cancer deaths, but causation remains unproven.
Judge rules former Abercrombie CEO competent to face sex-trafficking trial
A federal judge ruled former Abercrombie & Fitch CEO Michael Jeffries mentally competent to stand trial on alleged sex-trafficking charges after months of hospitalization.
Diagnostics are moving from central labs toward point-of-care and consumer testing
Coverage spans faster point-of-care molecular tests, cancer treatment-matching assays, and consumer blood-based reports, alongside laboratory services for infectious disease, genomics, and aging.
FDA approval puts an oral JAK-pathway treatment for dermatomyositis in focus
Coverage centers on reported FDA approval of Lisraya, an oral JAK-pathway drug for adults with dermatomyositis, alongside broader research and industry activity in inflammation.
Health tech coverage spans startups, digital tools and medical-device investment
Coverage groups together health-tech startups, digital-health initiatives, wearable-company finances, drone delivery and a Pennsylvania ultrasound manufacturing expansion.
NASA calls off the rescue of its aging Swift space telescope
NASA and Katalyst Space Technologies have ended a planned rescue of the aging Swift space telescope after the proposed Link spacecraft developed persistent control and positioning problems.
Antibody-drug conjugates advance through new delivery strategies and cancer trials
Antibody-drug conjugates are drawing attention as developers test targeting and release strategies, advance candidates in trials, and pursue biosimilar options for HER2-positive cancer.
Gene therapy advances are unfolding alongside unresolved safety and access questions
Recent coverage spans experimental gene editing, improved stem-cell collection for sickle cell disease, potential brain therapies, and regulatory holds tied to safety findings.
The FDA is seeking input on how to regulate generative AI medical devices
The FDA is seeking public feedback on a proposed framework for regulating generative AI-enabled medical devices, including risk classification and competency-based evaluation.